No Data
No Data
Clarity Pharmaceuticals Target Price Riased 44% to A$4.50/Share by Wilsons>CU6.AU
Clarity Pharmaceuticals Target Price Riased 44% to A$4.50/Share by Wilsons>CU6.AU
Clarity Pharmaceuticals Target Price Raised 2.6% to A$4.00/Share by Bell Potter>CU6.AU
Clarity Pharmaceuticals Target Price Raised 2.6% to A$4.00/Share by Bell Potter>CU6.AU
Clarity Pharmaceuticals Completes AU$10.8 Million Retail Entitlement Offer
Clarity Pharmaceuticals (ASX:CU6) has completed an about AU$10.8 million retail entitlement offer at AU$2.55 per new share, according to a Wednesday Australian bourse filing. The retail component now
Clarity Pharmaceuticals Price Target Raised 2% to A$3.12/Share by Wilsons
Clarity Pharmaceuticals Price Target Raised 2% to A$3.12/Share by Wilsons
Clarity Pharmaceuticals Signs Supply Agreement With NorthStar Medical Radioisotopes
Clarity Pharmaceuticals (ASX:CU6) signed a clinical supply agreement with NorthStar Medical Radioisotopes for the production of 67Cu-SAR-bisPSMA drug product for Phase I/II and Phase III trials for pr
Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip Are Sinking Today
In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on track to end the shortened week on a positive note. At the time of writing, the benchmark index is up 0.9% to 7,889.3 points.
No Data